In addition to his role as CEO and senior analyst at Friedland Equity Research (www.FriedlandEquityResearch.com). Jeffrey Friedland is also Managing Director of Singapore based Friedland Global Capital Pte. Ltd.(www.friedlandcapital.com) Since 1979 Mr. Friedland has assisted hundreds of companies worldwide with their business planning and financing objectives. In addition to providing corporate finance advisory services, the services provided by Mr. Friedland have included obtaining venture capital, mergers and acquisitions, and assistance to companies regarding financing their growth and going public. Mr. Friedland has traveled globally with the management of companies with the objectives of assisting the companies with obtaining capital, expanding globally and entering into strategic alliances. Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, USA Today, The South China Morning Post (Hong Kong) and Forbes. He has also been featured over 60 times on Financial News Network, which is now CNBC, Bloomberg Information Radio, and Bloomberg TV. Mr. Friedland has been a frequent speaker at various tradeshows, conferences, conventions and meetings throughout North America, Europe and Asia, most recently at a Bloomberrg China Conference at the Tate Modern in London. In November 2012 he will be presenting at private equity investor event in Scottsdale Arizona on the topic, "The Effect of China's Leadership Changes on Investment Opportunities in China."
do my own private investing, through due dilligence..I was introduced to the CEO of Polymedix, He showed me a visual presentation of Brilaciden on his laptop. I was impressed . The R & D costs are overwhelming. CTIX now owns all the necessary data of Polymedix to continue the R & D. I believe CTIX would be a good fit for Cubist,who have similar interests in these types of antibiotics
We at SinoValues unabashedly believe that Asian markets for decades to come shall be a place of great wealth generation for those willing to participate.
We primarily invest in American listed Chinese securities. While we dedicate part of our portfolio to swing trading, our long-term growth consists of small & mid cap, emerging stocks- mainly Chinese mining, retail, and internet.
Companies that have potential for double-digit growth, dividend payments, and a discount to intrinsic value are the long-term focus.
We mainly use technical and fundamental analysis for our short term trades.
When we are not looking for the next best Chinese growth story, life is enjoyed through traveling, golf, board games, antiquing, and enjoying time with friends.
Kalle Raus has majored in Finance and minored in Business. With over 10 years of experience in the markets, both on equity, futures, forex and options side, Kalle Raus is well versed in investing and markets, beeing through two significant market down-turns and bull markets. Right now he is investing with his personal portfolio. He is also open to interesting job offers in the fund managent industry.
I started to invest in 2007 and since then I've seen the housing crash the Euro crisis and now the great QE debate. From what I've seen, a buy and hold strategy can work - if you can time the market! But, from my experience, market timing is impossible. I rather focus on companies with strong fundamentals, safe dividends and some kind of growth story.